Robin Casey

1.2k total citations
27 papers, 817 citations indexed

About

Robin Casey is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Robin Casey has authored 27 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Physiology and 7 papers in Clinical Biochemistry. Recurrent topics in Robin Casey's work include Lysosomal Storage Disorders Research (9 papers), Metabolism and Genetic Disorders (7 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Robin Casey is often cited by papers focused on Lysosomal Storage Disorders Research (9 papers), Metabolism and Genetic Disorders (7 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Robin Casey collaborates with scholars based in Canada, United States and Switzerland. Robin Casey's co-authors include Grant A. Mitchell, David H. George, Barbara K. Goodman, Shlomo Almashanu, Cassandra Obie, David Valle, Gary Steel, Marie Lambert, Chien-an A. Hu and Priya S. Kishnani and has published in prestigious journals such as Nature Genetics, The Journal of Physical Chemistry B and The American Journal of Human Genetics.

In The Last Decade

Robin Casey

27 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Casey Canada 16 348 287 181 163 105 27 817
Fatih Süheyl Ezgü Türkiye 15 296 0.9× 262 0.9× 136 0.8× 139 0.9× 75 0.7× 100 724
Diana Ballhausen Switzerland 19 546 1.6× 347 1.2× 356 2.0× 158 1.0× 141 1.3× 46 1.1k
Johannis B.C. de Klerk Netherlands 12 441 1.3× 469 1.6× 222 1.2× 315 1.9× 99 0.9× 12 909
Hilary Vallance Canada 18 519 1.5× 221 0.8× 469 2.6× 145 0.9× 95 0.9× 65 1.0k
F. Sedel France 18 384 1.1× 682 2.4× 365 2.0× 210 1.3× 109 1.0× 35 1.3k
Sema Kalkan Uçar Türkiye 14 205 0.6× 203 0.7× 113 0.6× 99 0.6× 74 0.7× 86 632
Ksenija Fumić Croatia 15 498 1.4× 248 0.9× 329 1.8× 286 1.8× 80 0.8× 62 868
J. T. R. Clarke Canada 15 225 0.6× 186 0.6× 131 0.7× 69 0.4× 70 0.7× 23 560
Carolina Fischinger Moura de Souza Brazil 19 507 1.5× 427 1.5× 362 2.0× 279 1.7× 170 1.6× 110 1.2k
Dimitar Gavrilov United States 15 403 1.2× 345 1.2× 437 2.4× 152 0.9× 102 1.0× 35 901

Countries citing papers authored by Robin Casey

Since Specialization
Citations

This map shows the geographic impact of Robin Casey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Casey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Casey more than expected).

Fields of papers citing papers by Robin Casey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Casey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Casey. The network helps show where Robin Casey may publish in the future.

Co-authorship network of co-authors of Robin Casey

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Casey. A scholar is included among the top collaborators of Robin Casey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Casey. Robin Casey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Case, Laura E., Carl Bjartmar, Claire Morgan, et al.. (2014). Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease. Neuromuscular Disorders. 25(4). 321–332. 44 indexed citations
2.
Auray‐Blais, Christiane, Michel Boutin, Paméla Lavoie, et al.. (2013). Gene therapy for Fabry disease patients: The importance of efficient biomarker monitoring. Molecular Genetics and Metabolism. 108(2). S21–S21. 1 indexed citations
3.
Sarnat, Harvey B., Laura Flores‐Sarnat, Robin Casey, Patrick Scott, & Aneal Khan. (2012). Endothelial ultrastructural alterations of intramuscular capillaries in infantile mitochondrial cytopathies: “Mitochondrial angiopathy”. Neuropathology. 32(6). 617–627. 14 indexed citations
4.
Khan, Anzalee, et al.. (2012). In Vivo Bone Architecture in Pompe Disease Using High-Resolution Peripheral Computed Tomography. JIMD Reports. 7. 81–88. 12 indexed citations
5.
West, Michael L., et al.. (2011). Agalsidase Alfa and Agalsidase beta Have Similar Effects on Outcomes in Fabry disease– results from the canadian Fabry disease initiative. Molecular Genetics and Metabolism. 102(2). S46–S46. 4 indexed citations
6.
Clarke, L., Anita C. Thomas, Sylvia Stöckler, et al.. (2011). Longitudinal observations of serum heparin cofactor II‐thrombin complex in treated Mucopolysaccharidosis I and II patients. Journal of Inherited Metabolic Disease. 35(2). 355–362. 18 indexed citations
7.
Auray‐Blais, Christiane, Joe T.R. Clarke, David G. Warnock, et al.. (2010). How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?. Clinica Chimica Acta. 411(23-24). 1906–1914. 92 indexed citations
8.
Yanovitch, Tammy L., Robin Casey, Suhrad G. Banugaria, & Priya S. Kishnani. (2010). Improvement of Bilateral Ptosis on Higher Dose Enzyme Replacement Therapy in Pompe Disease. Journal of Neuro-Ophthalmology. 30(2). 165–166. 38 indexed citations
9.
Bergmann, Anke, Inderneel Sahai, Adam Bagg, et al.. (2009). Thiamine-Responsive Megaloblastic Anemia: Identification of Novel Compound Heterozygotes and Mutation Update. The Journal of Pediatrics. 155(6). 888–892.e1. 66 indexed citations
10.
Randall, Derrick R., Graham Sinclair, Anita C. Thomas, et al.. (2008). Heparin cofactor II–thrombin complex: A biomarker of MPS disease. Molecular Genetics and Metabolism. 94(4). 456–461. 45 indexed citations
11.
Franzen, Stefan, Audrius Jasaitis, Jennifer Belyea, et al.. (2006). Hydrophobic Distal Pocket Affects NO−Heme Geminate Recombination Dynamics in Dehaloperoxidase and H64V Myoglobin. The Journal of Physical Chemistry B. 110(29). 14483–14493. 13 indexed citations
12.
Francis, Gordon A., Gang Li, Robin Casey, et al.. (2006). Peroxisomal proliferator activated receptor-γ deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3). BMC Medical Genetics. 7(1). 3–3. 51 indexed citations
13.
Corzo, Deyanira, William T. Gibson, Grant A. Mitchell, et al.. (2002). Contiguous Deletion of the X-Linked Adrenoleukodystrophy Gene (ABCD1) and DXS1357E: A Novel Neonatal Phenotype Similar to Peroxisomal Biogenesis Disorders. The American Journal of Human Genetics. 70(6). 1520–1531. 50 indexed citations
14.
George, David H. & Robin Casey. (2001). Menkes Disease after Copper Histidine Replacement Therapy: Case Report. Pediatric and Developmental Pathology. 4(3). 281–288. 19 indexed citations
15.
Obie, Cassandra, Barbara K. Goodman, Chien-an A. Hu, et al.. (1999). Hyperornithinaemia- hyperammonaemia- homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nature Genetics. 22(2). 151–158. 152 indexed citations
16.
Macaulay, Robert, Noel Lowry, & Robin Casey. (1998). Pathologic findings of multiple sulfatase deficiency reflect the pattern of enzyme deficiencies. Pediatric Neurology. 19(5). 372–376. 7 indexed citations
17.
Christodoulou, John, David M. Danks, Bibudhendra Sarkar, et al.. (1998). Early treatment of Menkes disease with parenteral Cooper-Histidine: Long-term follow-up of four treated patients. American Journal of Medical Genetics. 76(2). 154–164. 73 indexed citations
18.
Christodoulou, John, David M. Danks, Bibudhendra Sarkar, et al.. (1998). Early treatment of Menkes disease with parenteral Cooper‐Histidine: Long‐term follow‐up of four treated patients. American Journal of Medical Genetics. 76(2). 154–164. 1 indexed citations
19.
Habbick, Brian F., Josephine L. Nanson, R. E. Snyder, & Robin Casey. (1997). Mortality in Foetal Alcohol Syndrome. Canadian Journal of Public Health. 88(3). 181–183. 20 indexed citations
20.
Casey, Robin, et al.. (1995). Association of Infantile Neuroaxonal Dystrophy and Osteopetrosis: A Rare Autosomal Recessive Disorder. Pediatric Neurosurgery. 22(6). 321–327. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026